Synapse News

2 of 29

VoxNeuro closes $4 million to help diagnose concussions and Alzheimer’s diseases

ORIGINAL ARTICLE, Josh Scott,, October 20, 2022 Backed by decades of research, VoxNeuro aims to bring objectivity to brain health assessments. Cognitive health assessments are something that a lot of people have experienced, whether you’re a professional athlete or weekend warrior who has suffered a potential brain injury, or an…

October 20, 2022 | Alex Muggah
Life Science innovator networking at Synapse Competition in the McMaster Innovation Park atrium.

Ontario’s Premier Life Science Competition Celebrates 10 Years of Health Innovation

Applications are now open for this year’s cohort of innovative startups Hamilton – October 12, 2022 – Fresh off the heels of celebrating innovation at the recent LiONS LAIR pitch competition and gala event, Innovation Factory has turned its attention to the 2023 Synapse Life Science Pitch Competition, now in its 10th year. …

October 19, 2022 | Alex Muggah

$3.1 million CIHR grant funds major McMaster study on pandemic’s impact on child health

A McMaster-led interdisciplinary team of researchers, policy and community partners is launching a major investigation into the pandemic’s impact on Canadian children and youth.   The study of almost 27,000 children and youth ages five to 21 is being supported by a $3.1 million grant from the Canadian Institutes of Health Research…

October 6, 2022 | Alex Muggah

McMaster University collaborating with Verv Technologies to advance blood testing technology, leveraging $314k grant from NSERC

Verv Technologies and McMaster University announced a new collaboration that will further develop Verv’s technology to improve at-home healthcare. A $314,000 investment from the Natural Sciences and Engineering Research Council of Canada is allowing the partners to work together to develop a series of blood tests that have the potential to…

October 4, 2022 | Alex Muggah

Llif Healthcare and Chirp among Big Winners at at 12th Annual LiONS LAIR Awards Gala.

Congratulations to the 2022 LiONS LAIR winners, who collected $50,000.  Innovation Factory’s LiONS LAIR event showcases the region’s innovative start-up community and gives up-and-coming entrepreneurs the opportunity to pitch their business to a panel of Hamilton’s top business experts and potential investors. Second place winner Shawn…

September 29, 2022 | Alex Muggah

VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease

VoxNeuro Inc., a Hamilton-based commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology. In…

September 27, 2022 | Alex Muggah

Innovation Parks, Clinical Infrastructure and Supportive Networks are three ways smart site selection is helping life sciences companies turn innovation into commercialisation

Making a smart site selection could drive the commercialisation of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialisation. Three areas in particular, are making site selection easier: innovation parks, clinical infrastructure and…

September 23, 2022 | Alex Muggah

SOPHIE participant Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants

Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants. The lead investor in the financing was…

September 21, 2022 | Alex Muggah

Adapsyn Bioscience enters into strategic collaboration with Evotec

Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug…

September 21, 2022 | Alex Muggah